Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: dificid  fda  approval  drug  cdad  clostridium  treatment  disease  optimer  pharmaceuticals  health  healthcare  multivu  50177  novartis  ctl019  clinical  data  pediatric  children  young  adults  leukemia  refractory  acute  lymphoblastic  multivu  7393851  fda  brain  cancer  health  healthcare  treatment  medicine  glioma  multivu  7944251  be  youthful  se  joven  book  ebook  aging  youth  beauty  health  wellness  cosmetic  dermatology  skincare  multivu  7513051  torax  linx  medical  device  testimonial  gastroesophageal  reflux  disease  gerd  treatment  patients  health  multivu  60077  edwards  lifesciences  valve  study  results  high-risk  surgical  patients  health  clinical  trials  aortic  multivu  48895  soy  health  food  women  breast  cancer  myth  cancer  research  safety  multivu  7877951  emdeon  atigeo  big  data  ytics  patient  care  payment  revenue  management  information  exchange  healthcare  multivu  59755  emdeon  edge  payment  integrity  cost  management  claim  fraud  solutions  healthcare  multivu  48121  emdeon  clinical  exchange  health  information  solutions  care  business  technology  healthcare  multivu  48120  epilepsy  treatment  upsher  smith  practice  management  billing  codes  neurology  doctors  medicine  healthcare  multivu  58062  euclid  cdi  hospital  clinic  diagnosis  europe  awareness  test  healthcare  multivu  71400524 
Search // clinical
Results 37-48 of 101 for ' clinical ' (0 seconds)
Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition. The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting. To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
Categories // Business  Science and Technology 
Added: 4686 days ago by MultiVuVideos
Runtime: 1m22s | Views: 4325 | Comments: 1
Not yet rated
 

 

 

Rules-Based Medicine, Inc. (RBM), today announced the widespread commercial availability of VeriPsych™, the first and only blood-based diagnostic test to aid in confirming the diagnosis of recent onset schizophrenia, a potentially devastating and costly mental illness that affects about 24 million people worldwide. VeriPsych is an innovative molecular diagnostic tool designed to complement the healthcare provider’s clinical impression. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/rulesbasedmedicine/46237/
Categories // People and Blog 
Added: 5158 days ago by MultiVuVideos
Runtime: 4m9s | Views: 10457 | Comments: 0
Not yet rated
 

 

 

Medical researchers are making unprecedented progress into understanding why women suffer disproportionately from a number of diseases. Those insights are providing information to help develop medicines to attack diseases such as osteoporosis, multiple sclerosis, depression, rheumatoid arthritis and age-related macular degeneration, all of which affect more women than men. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/50270/
Categories // News and Politics 
Added: 4942 days ago by MultiVuVideo
Runtime: 1m56s | Views: 9899 | Comments: 0
Not yet rated
 

 

 

Orbis, the international nonprofit that unites the world in the fight against blindness, is proud to land its new, state-of-the-art Flying Eye Hospital in Shenyang, China this week to commence its first training program, running from September 5 - 23. Six years in the making, the third-generation Flying Eye Hospital is the world’s only mobile ophthalmic teaching hospital on board an MD-10 aircraft, donated by FedEx. Hundreds of experts have come together to combine the latest in avionics, hospital engineering, technology and clinical expertise to make the new Flying Eye Hospital a reality. It features modular design, 3D technology and live broadcast capabilities, which enables Orbis and their expert Volunteer Faculty to train more doctors, nurses and healthcare professionals—ultimately treating more people and restoring their sight. “Today, I am incredibly proud that our Flying Eye Hospital can get to work on its first program,” Bob Ranck, Orbis CEO and President, said. “It is a testament to the hundreds of volunteers, global corporate partners, governments and other individuals who have worked tirelessly to make this unique aircraft a reality, and we thank them one and all. Our mission at Orbis is to bring the world together to fight blindness, and the Flying Eye Hospital is an important tool for achieving this. It is an equal-parts teacher, envoy and advocate for the right to sight. We are excited to start this new chapter in Orbis history here in Shenyang, China.” To view the multimedia release go to: http://www.multivu.com/players/English/7316251-orbis-flying-eye-hospital/
Categories // Miscellaneous 
Added: 2996 days ago by MultiVuVideos
Runtime: 5m11s | Views: 973 | Comments: 0
    
 

 

 

Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years. Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government. AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60. To view the multimedia release go to: http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Categories // Miscellaneous 
Added: 2956 days ago by MultiVuVideos
Runtime: 0m59s | Views: 785 | Comments: 0
Not yet rated
 

 

 

Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols. When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.” To view the multimedia release go to: https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Categories // Miscellaneous 
Added: 2494 days ago by MultiVuVideos
Runtime: 3m51s | Views: 748 | Comments: 3
Not yet rated
 

 

 

Evidence from the Childhood Cancer Survivor Study suggests that changes in childhood cancer treatment have reduced deaths from the late effects of cancer treatment and extended the lives of childhood cancer survivors. St. Jude Children’s Research Hospital investigators led the research, which will be presented today at the plenary session of the 2015 annual meeting of the American Society of Clinical Oncology (ASCO). The study is one of four being featured at the plenary session press briefing, which highlights research that ASCO deems as having the highest scientific merit and greatest potential to affect patient care. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7532851-st-jude-cancer-research/
Categories // People and Blog 
Added: 3461 days ago by MultiVuVideos
Runtime: 3m25s | Views: 813 | Comments: 1
Not yet rated
 

 

 

When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available. In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available. To view the multimedia release go to: https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Categories // Miscellaneous 
Added: 2270 days ago by MultiVuVideos
Runtime: 2m26s | Views: 820 | Comments: 1
Not yet rated
 

 

 

Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options. In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe. To view the multimedia release go to: http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Categories // Miscellaneous 
Added: 2998 days ago by MultiVuVideos
Runtime: 2m49s | Views: 629 | Comments: 0
Not yet rated
 

 

 

After only 16 weeks of existence, foetuses hear and respond to music as long as it is emitted from their mother’s vagina. Foetuses respond to this stimulus by opening their mouths and pulling their tongues out as far as possible, making vocalisation movements – prior to the acquisition of language. This is the main conclusion of the study conducted by the team of Institut Marquès, which boasts the collaboration of Alberto Prats, Professor of Anatomy and Human Embryology of the Faculty of Medicine of the University of Barcelona. The study, entitled “Foetal facial expression in response to intravaginal music emission”, is published this week in the journal Ultrasound of the British Medical Ultrasound Society (BMUS). According to Dr. Marisa López-Teijón, the Head of Assisted Reproduction at Institut Marquès and the principal researcher and author of the clinical study: “We have discovered that the formula for foetuses to hear like us is to emit music from the mother’s vagina. They barely hear the sound that reaches them through their mother’s abdomen: the soft tissues of the abdomen and the inside of the mother’s body absorb the soundwaves”. To view the multimedia release go to: http://www.multivu.com/players/English/7647351-how-foetuses-hear-musical-stimuli/
Categories // Miscellaneous 
Added: 3334 days ago by MultiVuVideos
Runtime: 2m49s | Views: 733 | Comments: 0
Not yet rated
 

 

 

Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans. To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Added: 4000 days ago by MultiVuVideos
Runtime: 6m52s | Views: 1467 | Comments: 1
Not yet rated
 

 

 

Caralluma Fimbriata is widely acknowledged as the MOST POWERFUL weight loss and appetite suppressant that is completely natural and 100% side effect free! To learn all about Caralluma and what it means for YOU CLICK http://carallumaforyou.com/ To learn about the bestselling Caralluma product CLICK http://carallumaforyou.com/caralluma-actives
Categories // Miscellaneous 
Added: 4578 days ago by johngeltkn
Runtime: 1m17s | Views: 4440 | Comments: 1
Not yet rated
 

 

 

Page 4 of 9  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.